Genomics

Long-context DNA models are limited by token-mixing cost and by how compression allocates representational budget across the genome. Existing approaches operate close to base-pair resolution, apply fixed downsampling, or learn content-dependent chunks without an explicit genomic budget, making long-context pretraining expensive and difficult to control. We introduce GeneZip, a region-aware DNA compression framework that combines H-Net-style dynamic routing with a Region-Aware Ratio (RAR) objective and bounded routing. GeneZip uses static gene-structure annotations during compression training to specify region-wise base-pairs-per-token (BPT) targets; at inference time, it compresses raw unseen DNA without annotations. GeneZip provides three main benefits. First, it is effective: GeneZip variants achieve the best validation PPL among encoder-based compressors, with GeneZip-70M operating at 137.6 BPT, and across four reproducible DNALongBench tasks--contact map prediction, eQTL prediction, enhancer-target gene prediction, and transcription-initiation signal prediction--GeneZip obtains the best average rank among compared sequence models. Second, it is redundancy-aware: a post-hoc RepeatMasker/TRF analysis shows that, without repeat supervision, GeneZip assigns higher local BPT to TE-derived interspersed repeats and tandem repeats, two major classes of repetitive DNA sequence redundancy. Third, it is efficient: by reducing the effective token-mixing length, GeneZip enables longer-context and larger-capacity pretraining, including 128K-context and 636M-parameter variants on a single A100 80GB GPU, and fine-tunes the eQTL task 50.4x faster than JanusDNA (50 vs. 2520 minutes). These results establish GeneZip as an effective, redundancy-aware, and efficient compression interface for long-context DNA modeling.

Genomic Foundation Models (GFMs) typically rely on Masked Language Modeling (MLM) or Next-Token Prediction (NTP) to learn the "Laws of Nature". While effective at capturing local syntax, these generative paradigms prioritize token-level reconstruction over high-level functional context. We introduce JEPA-DNA, a model-agnostic continual training framework that integrates a Joint-Embedding Predictive Architecture (JEPA) with traditional generative objectives. By supervising global sequence embeddings in a latent space, JEPA-DNA forces models to predict the functional representations of masked genomic segments, shifting the learning signal from token recovery to semantic alignment. We evaluate JEPA-DNA on 17 diverse genomic benchmark tasks, demonstrating consistent gains in linear probing and zero-shot performance regardless of the underlying GFM architecture or generative objective, and establishing a new state-of-the-art for GFMs under the linear-probing protocol. Through extensive ablation studies, we further characterize the synergistic interplay between generative and latent objectives. Our code is provided in the supplementary material.

With the introduction of cyber-physical genome sequencing and editing technologies, such as CRISPR, researchers can more easily access tools to investigate and create remedies for a variety of topics in genetics and health science (e.g. agriculture and medicine). As the field advances and grows, new concerns present themselves in the ability to predict the off-target behavior. In this work, we explore the underlying biological and chemical model from a data driven perspective. Additionally, we present a machine learning based solution named Guide-Guard to predict the behavior of the system given a gRNA in the CRISPR gene-editing process with 84% accuracy. This solution is able to be trained on multiple different genes at the same time while retaining accuracy.

Motivation: Interpretability is not optional in biology: understanding gene regulation requires models whose learned structure can be directly interrogated, not merely accurate predictors whose internals resist mapping onto regulatory relationships. We ask whether an architecture mirroring the central dogma yields attention and gradient maps that recover known regulatory elements and networks in inspectable form. Results: Central Dogma Transformer II (CDT-II) mirrors the central dogma in its architecture -- DNA self-attention, RNA self-attention, and DNA-to-RNA cross-attention -- requiring only genomic embeddings and raw per-cell expression. On K562 CRISPR interference (CRISPRi) data with five genes held out entirely, CDT-II predicts perturbation effects (per-gene mean r = 0.84), recovers the GFI1B regulatory network (6.6-fold enrichment, P = 3.5 x 10^-17), and concentrates cross-attention on ENCODE regulatory elements including CTCF sites (mean 7.67x across 28 target genes, P < 0.001). Gradient attribution predicts consequences of perturbing therapeutic targets (mean r = 0.82). For TFRC, target of the anti-TfR1 antibody PPMX-T003, it identifies erythrocyte-structure, iron-dependent DNA-synthesis and oxidative-stress genes, matching anemia and ferroptosis reported clinically and preclinically -- without clinical data as input. CDT-II acts as an AI microscope, surfacing clinically relevant regulatory structure from perturbation experiments alone. Availability: Source code is available at https://github.com/nobusama/CDT2. Pre-computed embeddings, training data, and model weights are available at https://huggingface.co/datasets/nobusama17/CDT2-data.

Gene expression analysis holds the key to many biomedical discoveries, yet extracting insights from raw transcriptomic data remains challenging due to the complexity of multiple large, semi-structured files and the need for extensive domain expertise. Current approaches either rely on inflexible workflows that fail in edge cases or fully autonomous agents that lack the precision required for rigorous scientific inquiry. GenoMAS addresses this by presenting a team of LLM-based agents that integrates structured workflows with autonomous adaptability, orchestrating diverse specialized agents through typed message-passing protocols. At its core lies a guided-planning framework where programming agents decompose task guidelines into Action Units and dynamically choose to advance, revise, bypass, or backtrack, maintaining logical coherence while adapting to the idiosyncrasies of genomic data. On the GenoTEX benchmark, GenoMAS achieves 89.13% CSC for data preprocessing and 60.48% $F_1$ for identifying trait-associated genes, surpassing prior art by 10.61% and 16.85%. Beyond transcriptomics, it outperforms strong agent baselines on ScienceAgentBench and DiscoveryBench, two independent bioinformatics benchmarks. Qualitative analysis shows that GenoMAS identifies gene-phenotype associations that are biologically plausible and corroborated by the literature.

Natural Language Processing (NLP) has transformed various fields beyond linguistics by applying techniques originally developed for human language to the analysis of biological sequences. This review explores the application of NLP methods to biological sequence data, focusing on genomics, transcriptomics, and proteomics. We examine how various NLP methods, from classic approaches like word2vec to advanced models employing transformers and hyena operators, are being adapted to analyze DNA, RNA, protein sequences, and entire genomes. The review also examines tokenization strategies and model architectures, evaluating their strengths, limitations, and suitability for different biological tasks. We further cover recent advances in NLP applications for biological data, such as structure prediction, gene expression, and evolutionary analysis, highlighting the potential of these methods for extracting meaningful insights from large-scale genomic data. As language models continue to advance, their integration into bioinformatics holds immense promise for advancing our understanding of biological processes in all domains of life.